Amgen Inc. Q2 Profit Decreases, But Beats Estimates

Amgen Inc. (AMGN) revealed earnings for second quarter that decreased from the same period last year but beat the Street estimates.

The company's bottom line came in at $746 million, or $1.38 per share. This compares with $1.379 billion, or $2.57 per share, in last year's second quarter.

Excluding items, Amgen Inc. reported adjusted earnings of $2.691 billion or $4.97 per share for the period.

Analysts on average had expected the company to earn $4.59 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 20.1% to $8.388 billion from $6.986 billion last year.

Amgen Inc. earnings at a glance (GAAP) :

-Earnings (Q2): $746 Mln. vs. $1.379 Bln. last year.
-EPS (Q2): $1.38 vs. $2.57 last year.
-Revenue (Q2): $8.388 Bln vs. $6.986 Bln last year.

-Guidance:
Full year EPS guidance: $19.10 - $20.10
Full year revenue guidance: $32.8 - $33.8 Bln

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com